// App-Quantinova.ai

O39 : 11beta-hydroxysteroid dehydrogenase type 1 regulates the suppression of inflammation, joint destruction and systemic bone loss in a model of chronic inflammation

Researchers

Presenter

  • Rowan S Hardy

Principal Investigators

  • Chloe Fenton

  • Amy Naylor

  • Adam Croft

  • Gareth Lavery

  • Christopher Buckley

  • Mark Cooper

  • Karim Raza

Medical Centers

  • Institute of Inflammation and Aging, The University of Birmingham, Birmingham, UNITED KINGDOM

  • Institute of Metabolism and Systems Research, University of Birmingham, Birmingham, United Kingdom

  • ANZAC Research Institute, University of Sydney, Sydney, AUSTRALIA

Locations

  • United Kingdom

  • Australia

Companies

  • N/A

Study Components

Therapeutic Area

  • Obstetrics/Gynecology

Disease

  • Twin-reversed arterial perfusion

Biomarkers

  • Triiodothyronine receptor auxiliary protein

Drug/Treatment

  • Glucocorticoid

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved